US Stock MarketDetailed Quotes

Jasper Therapeutics (JSPR)

Watchlist
  • 1.570
  • +0.050+3.29%
Close Jan 22 16:00 ET
  • 1.570
  • 0.0000.00%
Pre 08:00 ET
43.93MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics (JSPR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
Net income from continuing operations
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Operating gains losses
----
----
----
-98.09%11K
----
----
----
----
107.99%575K
--0
Depreciation and amortization
-57.67%229K
-13.71%258K
-3.13%279K
23.92%1.37M
-13.43%245K
96.01%541K
8.73%299K
5.11%288K
13.64%1.11M
3.66%283K
Other non cash items
118.40%273K
162.50%315K
66.38%193K
22.44%491K
54.76%130K
154.82%125K
137.74%120K
-86.56%116K
107.44%401K
833.33%84K
Change In working capital
-109.73%-187K
786.03%8.88M
-8.46%-3.88M
-96.61%173K
158.40%831K
-53.37%1.92M
-31.37%1M
-478.54%-3.58M
886.29%5.1M
-21.52%-1.42M
-Change in receivables
----
----
----
--0
--0
--0
--0
--0
200.00%663K
--0
-Change in prepaid assets
52.82%-209K
3,382.14%919K
-192.20%-201K
-376.79%-2.12M
-167.14%-1.87M
-131.55%-443K
-107.93%-28K
175.17%218K
145.83%767K
48.42%-700K
-Change in payables and accrued expense
-82.45%432K
699.80%8.05M
-4.88%-3.66M
-47.21%2.75M
489.34%2.76M
-15.66%2.46M
-4.46%1.01M
-558.08%-3.49M
495.59%5.2M
223.10%469K
-Change in other current assets
-72.00%42K
30.77%340K
460.00%288K
189.55%523K
120.71%193K
341.18%150K
-7.14%260K
-335.29%-80K
-412.28%-584K
-331.48%-932K
-Change in other current liabilities
-83.00%-452K
-83.54%-435K
-35.19%-315K
-2.96%-973K
1.54%-256K
-4.66%-247K
-4.41%-237K
-4.95%-233K
-183.55%-945K
-117.98%-260K
Cash from discontinued investing activities
Operating cash flow
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
Investing cash flow
Cash flow from continuing investing activities
0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
-274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
Net PPE purchase and sale
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
Cash from discontinued investing activities
Investing cash flow
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
Financing cash flow
Cash flow from continuing financing activities
315,322.22%28.39M
3,304.97%6.16M
0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
Net common stock issuance
--514K
--5.94M
--0
-53.49%47.2M
--0
--0
--0
-53.49%47.2M
--101.48M
--0
Proceeds from stock option exercised by employees
309,611.11%27.87M
23.20%223K
--0
52.43%689K
1,132.14%345K
-75.00%9K
-49.16%181K
381.25%154K
721.82%452K
0.00%28K
Net other financing activities
----
----
----
----
----
----
----
----
---960K
---299K
Cash from discontinued financing activities
Financing cash flow
315,322.22%28.39M
3,304.97%6.16M
--0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
Net cash flow
Beginning cash position
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
125.78%87.3M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
-54.53%38.67M
103.02%104.28M
Current changes in cash
179.55%11.39M
20.31%-9.29M
-172.30%-22.84M
-131.35%-15.25M
-22.88%-20.87M
-19.86%-14.32M
14.22%-11.66M
-65.35%31.59M
204.87%48.64M
-33.70%-16.98M
End cash Position
-44.77%51.32M
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
-17.47%72.05M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
125.78%87.3M
Free cash flow
-18.66%-17M
-30.61%-15.46M
-44.93%-22.84M
-20.67%-63.15M
-27.06%-21.23M
-19.57%-14.33M
10.89%-11.84M
-52.12%-15.76M
-12.71%-52.33M
-31.28%-16.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M
Net income from continuing operations -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Operating gains losses -------------98.09%11K----------------107.99%575K--0
Depreciation and amortization -57.67%229K-13.71%258K-3.13%279K23.92%1.37M-13.43%245K96.01%541K8.73%299K5.11%288K13.64%1.11M3.66%283K
Other non cash items 118.40%273K162.50%315K66.38%193K22.44%491K54.76%130K154.82%125K137.74%120K-86.56%116K107.44%401K833.33%84K
Change In working capital -109.73%-187K786.03%8.88M-8.46%-3.88M-96.61%173K158.40%831K-53.37%1.92M-31.37%1M-478.54%-3.58M886.29%5.1M-21.52%-1.42M
-Change in receivables --------------0--0--0--0--0200.00%663K--0
-Change in prepaid assets 52.82%-209K3,382.14%919K-192.20%-201K-376.79%-2.12M-167.14%-1.87M-131.55%-443K-107.93%-28K175.17%218K145.83%767K48.42%-700K
-Change in payables and accrued expense -82.45%432K699.80%8.05M-4.88%-3.66M-47.21%2.75M489.34%2.76M-15.66%2.46M-4.46%1.01M-558.08%-3.49M495.59%5.2M223.10%469K
-Change in other current assets -72.00%42K30.77%340K460.00%288K189.55%523K120.71%193K341.18%150K-7.14%260K-335.29%-80K-412.28%-584K-331.48%-932K
-Change in other current liabilities -83.00%-452K-83.54%-435K-35.19%-315K-2.96%-973K1.54%-256K-4.66%-247K-4.41%-237K-4.95%-233K-183.55%-945K-117.98%-260K
Cash from discontinued investing activities
Operating cash flow -20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M
Investing cash flow
Cash flow from continuing investing activities 0100.64%1K116.00%4K-99.25%-532K66.96%-76K-274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K
Net PPE purchase and sale --0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K
Cash from discontinued investing activities
Investing cash flow --0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K
Financing cash flow
Cash flow from continuing financing activities 315,322.22%28.39M3,304.97%6.16M0-52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K
Net common stock issuance --514K--5.94M--0-53.49%47.2M--0--0--0-53.49%47.2M--101.48M--0
Proceeds from stock option exercised by employees 309,611.11%27.87M23.20%223K--052.43%689K1,132.14%345K-75.00%9K-49.16%181K381.25%154K721.82%452K0.00%28K
Net other financing activities -----------------------------------960K---299K
Cash from discontinued financing activities
Financing cash flow 315,322.22%28.39M3,304.97%6.16M--0-52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K
Net cash flow
Beginning cash position -62.77%39.93M-58.60%49.22M-17.47%72.05M125.78%87.3M-10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M-54.53%38.67M103.02%104.28M
Current changes in cash 179.55%11.39M20.31%-9.29M-172.30%-22.84M-131.35%-15.25M-22.88%-20.87M-19.86%-14.32M14.22%-11.66M-65.35%31.59M204.87%48.64M-33.70%-16.98M
End cash Position -44.77%51.32M-62.77%39.93M-58.60%49.22M-17.47%72.05M-17.47%72.05M-10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M125.78%87.3M
Free cash flow -18.66%-17M-30.61%-15.46M-44.93%-22.84M-20.67%-63.15M-27.06%-21.23M-19.57%-14.33M10.89%-11.84M-52.12%-15.76M-12.71%-52.33M-31.28%-16.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -